Valeant Pharmaceuticals International, Inc.
Profile
Mailing Address: 2150 St. Elzéar Blvd. West
Laval, Quebec
H7L 4A8
Head Office Address: 2150 St. Elzéar Blvd. West
Laval, Quebec
H7L 4A8
Contact Name: Daniel Yelin Principal Regulator: Quebec
Business e-mail address: daniel.yelin@valeant.com Short Form Prospectus Issuer: Yes
Telephone Number: 514 940-6743 Reporting Jurisdictions: British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland
Fax Number: Stock Exchange: TSX, NYSE
Date of Formation: Mar 29 1994 Stock Symbol: VRX
Jurisdiction Where Formed: British Columbia Auditor: PricewaterhouseCoopers LLP
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 91911K Transfer Agent: AST Trust Company (Canada)
Financial Year-End: Dec 31 Size of Issuer (Assets): Over $1,000,000,000


View This Company's Documents